Simplex Trading
NXTC icon

Simplex Trading’s NextCure NXTC Stock Holding History

Simplex Trading’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-77
Closed – – 9755
2025
Q2 		$0 Buy
+77
New +$413 ﹤0.01% 9416
2024
Q3 		– Sell
-46
Closed – – 9239
2024
Q2 		$0 Buy
+46
New +$895 ﹤0.01% 9511
2022
Q2 		– Sell
-17
Closed -$888 – 10731
2022
Q1 		$0 Sell
17
-11
-39% -$688 ﹤0.01% 11100
2021
Q4 		$2K Buy
+28
New +$2.34K ﹤0.01% 10019
2021
Q2 		– Sell
-134
Closed -$13.7K – 10498
2021
Q1 		$16K Buy
134
+120
+857% +$17.4K ﹤0.01% 7627
2020
Q4 		$1K Sell
14
-11
-44% -$1.42K ﹤0.01% 8139
2020
Q3 		$2K Sell
25
-131
-84% -$16.1K ﹤0.01% 7440
2020
Q2 		$40K Buy
156
+55
+54% +$20.9K ﹤0.01% 5677
2020
Q1 		$45K Sell
101
-2
-2% -$1.07K ﹤0.01% 5242
2019
Q4 		$69K Buy
+103
New +$51.7K ﹤0.01% 4899

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's NXTC Position: Q3 2025 in Review

Simplex Trading sold out of NextCure (NXTC) in Q3 2025, closing a stake of 77 shares.

Simplex Trading first reported a position in NXTC in Q4 2019 and held it in 10 quarters. The position peaked at $69K in Q4 2019. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • Simplex Trading reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 77 NextCure shares in Q3 2025.
  • Simplex Trading first reported a position in NextCure in Q4 2019 and held it in 10 quarters.
  • Simplex Trading's NextCure position peaked at $69K in Q4 2019.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.